These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 17971651)
1. Neuroprotection in cerebral infarction: the opportunity of new studies. Pérez de la Ossa N; Dávalos A Cerebrovasc Dis; 2007; 24 Suppl 1():153-6. PubMed ID: 17971651 [TBL] [Abstract][Full Text] [Related]
2. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]
3. New perspectives on developing acute stroke therapy. Fisher M; Ratan R Ann Neurol; 2003 Jan; 53(1):10-20. PubMed ID: 12509843 [TBL] [Abstract][Full Text] [Related]
4. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Savitz SI; Fisher M Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989 [TBL] [Abstract][Full Text] [Related]
5. [Past, present and future of neuroprotection]. Mracek J Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotection from the collateral perspective. Liebeskind DS IDrugs; 2005 Mar; 8(3):222-8. PubMed ID: 15772894 [TBL] [Abstract][Full Text] [Related]
7. Effect of aminoguanidine on post-ischemic damage in rodent model of stroke. Vakili A; Zahedi-Khorasani M Pak J Pharm Sci; 2008 Jan; 21(1):24-8. PubMed ID: 18166515 [TBL] [Abstract][Full Text] [Related]
11. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Candelario-Jalil E Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170 [TBL] [Abstract][Full Text] [Related]
12. Novel therapies for acute ischemic stroke. Leker RR; Eichel R; Rafaeli G; Ben-Hur T Isr Med Assoc J; 2006 Nov; 8(11):788-92. PubMed ID: 17180832 [TBL] [Abstract][Full Text] [Related]
13. Ischemic stroke intervention requires mixed cellular protection of the penumbra. Barone FC Curr Opin Investig Drugs; 2009 Mar; 10(3):220-3. PubMed ID: 19333878 [TBL] [Abstract][Full Text] [Related]
14. [Emerging strategies for the treatment of acute ischemic stroke: lesson from focal ischemia model]. Yao H No To Shinkei; 2001 Jun; 53(6):525-33. PubMed ID: 11436336 [No Abstract] [Full Text] [Related]
16. Opioids modulate post-ischemic progression in a rat model of stroke. Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735 [TBL] [Abstract][Full Text] [Related]
17. Treatment with statins in the acute phase of ischemic stroke. Montaner J Expert Rev Neurother; 2005 Mar; 5(2):211-21. PubMed ID: 15853491 [TBL] [Abstract][Full Text] [Related]
18. Update on pharmacological strategies for stroke: prevention, acute intervention and regeneration. Legos JJ; Barone FC Curr Opin Investig Drugs; 2003 Jul; 4(7):847-58. PubMed ID: 14619407 [TBL] [Abstract][Full Text] [Related]
19. Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices. Savitz SI; Benatar M; Saver JL; Fisher M Cerebrovasc Dis; 2008; 26(2):156-62. PubMed ID: 18560219 [TBL] [Abstract][Full Text] [Related]
20. [Experimental models of cerebral ischemia]. Prieto-Arribas R; Moreno-Gutiérrez A; Simal-Hernández P; Pascual-Garvi JM; Matías-Guiu J; Roda JM; Barcia-Albacar JA Rev Neurol; 2008 Oct 16-31; 47(8):414-26. PubMed ID: 18937203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]